Lantern Pharma Inc.

NASDAQ: LTRN · Real-Time Price · USD
4.61
0.04 (0.88%)
At close: Aug 15, 2025, 3:59 PM
4.66
1.08%
After-hours: Aug 15, 2025, 04:32 PM EDT

Lantern Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-4.33M -4.54M -5.88M -4.51M -4.96M -5.44M -4.19M -3.16M -4.75M -3.87M -3.38M -2.26M -4.49M -4.12M -3.54M -4.05M -2.32M -2.45M
Depreciation & Amortization
4.5K 4.57K 51.22K 4.39K 46.27K 45.14K 44.32K 3.71K 3.51K 3.42K 2.76K 2.95K 2.38K 1.99K 1.99K 1.85K 1.58K 1.34K
Stock-Based Compensation
160.63K 147.75K 285.5K 179.17K 134.17K 134.06K 150.84K 190.75K 392.39K 333.53K 330.1K 301.11K 289.53K 267K 245.93K 224.41K 245.68K 245.52K
Other Working Capital
n/a 84.65K 575.43K 118.98K -962.83K 860.13K 459.31K -12.37K 500.32K 67.3K 380.34K -237.81K -1.16M -478.86K -438.94K -323.77K -84.69K -103.08K
Other Non-Cash Items
228.61K -60.25K 253.38K -345.76K -109.92K 62.25K -454.25K 39.61K 40.25K 14.01K -951 297.86K 36.15K 36.15K 275.99K 12.36K -85.12K 84.13K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 180.44K 95.5K 38.93K n/a n/a n/a 312.05K 225.24K 206.88K 14.91K n/a n/a
Change in Working Capital
n/a 69.09K 1.31M -914.35K -301.64K 2.13M 879.22K -780.24K 679.39K -240.35K 380.34K -2.38M 1.12M 263.66K 977.34K -867.23K 428.85K 60.99K
Operating Cash Flow
-3.94M -4.38M -3.97M -5.58M -5.19M -3.07M -3.39M -3.61M -3.59M -3.76M -2.67M -4.04M -2.73M -3.33M -2.04M -4.68M -1.73M -2.14M
Capital Expenditures
n/a -1.16K -3.08K -3.03K -4.27K -2.22K -5.08K -4.78K n/a -8.88K -6.96K -6.71K -14.18K n/a n/a -3.48K -12.01K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -261 -236 n/a -2.15M n/a 67.65 2.02M n/a n/a n/a n/a n/a
Purchase of Investments
-3.46M -4.98M 201.03K -3.12M -8.35M -6.01M -1.56M -731.49K -2.81M -3.1M -590.18K -1.32M -2M n/a -298.05K -999.02K -18.28M n/a
Sales Maturities Of Investments
15.27M n/a 3.25M -13.61M 8.15M 5.46M 1.82M 968K 2.35M 2.15M 1.2M 1.25M 1.49M 176.52K 64.09K n/a n/a n/a
Other Investing Acitivies
-8.22M 8.22M n/a 17.41M n/a n/a 261.26 236.51 -457.24 2.15M n/a -67.65 -2.02M 176.52 64.09K -3.48K -18.28K n/a
Investing Cash Flow
3.59M 3.24M 3.45M 680.35K -202.06K -556.17K 256.18K 231.73K -457.24K -960.88K 602.86K -74.36K -525.75K 176.52K -233.96K -1M -18.29M n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -500K n/a n/a n/a n/a n/a n/a -2.48M -939.67K n/a -0.00 n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.48M n/a n/a 299.79K -872.81K n/a n/a -73.71M
Financial Cash Flow
n/a n/a n/a 11.99K n/a 54.72K -500K n/a -690.8K n/a n/a n/a n/a -2.18K -872.81K n/a n/a 64.29M
Net Cash Flow
-316.19K -1.13M -591.74K -4.87M -5.38M -3.58M -3.63M -3.39M -4.06M -4.72M -2.06M -4.1M -3.29M -5.33M -3.14M -5.69M -20.02M 62.14M
Free Cash Flow
-3.94M -4.38M -3.97M -5.59M -5.19M -3.07M -3.39M -3.62M -3.59M -3.77M -2.68M -4.04M -2.75M -3.33M -2.04M -4.69M -1.74M -2.14M